S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
Critical asset just had biggest fall on record (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
Critical asset just had biggest fall on record (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Georgia's largest county is still repairing damage from January cyberattack

Daiichi Sankyo (DSNKY) News Today

$33.40
+0.54 (+1.64%)
(As of 03/1/2024 ET)
SourceHeadline
wsj.com logoDaiichi Sankyo Co. Ltd. ADR
wsj.com - February 25 at 8:45 AM
finance.yahoo.com logoDatopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
finance.yahoo.com - February 19 at 6:01 AM
morningstar.com logoDaiichi Sankyo Co Ltd 4568
morningstar.com - February 16 at 8:07 PM
news.yahoo.com logoDaiichi invests 1 billion eur near Munich to make precision cancer drugs
news.yahoo.com - February 16 at 10:07 AM
finance.yahoo.com logoDaiichi invests 1 bln eur near Munich to make precision cancer drugs
finance.yahoo.com - February 16 at 10:07 AM
finance.yahoo.com logoQ4 2023 Merck & Co Inc Earnings Call
finance.yahoo.com - February 2 at 1:56 AM
msn.com logoWhat's Going On With Pfizer Stock Today?
msn.com - January 25 at 7:09 PM
markets.businessinsider.com logoUS Patent Office Invalidates Seagen Patent In Daiichi Sankyo Dispute - Quick Facts
markets.businessinsider.com - January 17 at 8:17 AM
finance.yahoo.com logoU.S. Patent Office Invalidates Seagen Patent in Dispute between Daiichi Sankyo and Seagen
finance.yahoo.com - January 17 at 1:34 AM
marketwatch.com logoEsperion Therapeutics, Daiichi Sankyo Europe Reach $125M Payment Agreement Over Commercial Litigation
marketwatch.com - January 3 at 12:08 PM
msn.com logoWhy Pharmaceutical Company Esperion Therapeutics Shares Are Diving Today
msn.com - January 3 at 12:08 PM
markets.businessinsider.com logoMerck, Daiichi Sankyo Say FDA Grants Priority Review In U.S. For Patritumab Deruxtecan
markets.businessinsider.com - December 22 at 1:10 PM
finance.yahoo.com logoPatritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
finance.yahoo.com - December 22 at 8:10 AM
msn.com logoDaiichi Sankyo Co., - ADR (DSNKY) Price Target Increased by 8.80% to 38.57
msn.com - December 17 at 5:48 PM
businesswire.com logoDepixus Announces Strategic Collaboration With Daiichi Sankyo to Use MAGNA™ Technology to Accelerate RNA-targeted Drug Discovery
businesswire.com - December 12 at 7:30 AM
baystreet.ca logo300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates
baystreet.ca - December 1 at 12:24 PM
businesswire.com logoDaiichi Sankyo Demonstrates Breadth and Depth of Oncology Portfolio Across Multiple Cancers with New Data at ESMO Asia, SABCS and ASH
businesswire.com - December 1 at 12:24 PM
finance.yahoo.com logoJapan panel recommends approval of updated Daiichi Sankyo COVID shot- Kyodo
finance.yahoo.com - November 27 at 8:04 AM
investing.com logoDaiichi Sankyo Co., Ltd. (4568)
investing.com - October 31 at 2:39 PM
finance.yahoo.com logoMerck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?
finance.yahoo.com - October 31 at 2:39 PM
finance.yahoo.com logoMerck (MRK) Q3 Earnings Top Estimates, COVID Drug Boosts Sales
finance.yahoo.com - October 26 at 2:23 PM
finance.yahoo.com logo‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon
finance.yahoo.com - October 26 at 9:23 AM
bloomberg.com logoMerck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal
bloomberg.com - October 23 at 8:52 AM
finance.yahoo.com logoRaludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early Trial
finance.yahoo.com - October 22 at 8:38 AM
finance.yahoo.com logoNikkei Falls 0.5%, Dragged by Electronics, Retail Stocks
finance.yahoo.com - October 20 at 9:07 AM
news.yahoo.com logoMerck teams up with Daiichi Sankyo on antibody drug conjugate collaboration
news.yahoo.com - October 20 at 12:04 AM
barrons.com logoJapan's Daiichi Sankyo, Merck Announce $22bn Cancer Drug Deal
barrons.com - October 20 at 12:04 AM
reuters.com logoMerck signs $5.5 bln deal with Daiichi for cancer therapy development
reuters.com - October 20 at 12:04 AM
finance.yahoo.com logoExperimental Drug Wards Off Both Lung and Breast Cancer Progression in Trials
finance.yahoo.com - October 18 at 8:57 AM
finance.yahoo.com logoDaiichi Sankyo Showcases Progress in Developing New Standards of Care for Patients with Industry-Leading DXd ADC Portfolio Across Multiple Cancers at ESMO
finance.yahoo.com - October 16 at 9:44 AM
finance.yahoo.com logoNikkei Falls 1.1%, Dragged by Pharma, Electronics Stocks
finance.yahoo.com - September 26 at 7:54 AM
finance.yahoo.com logoU.S. Stocks Open Lower After S&P 500 Logs Three Straight Weeks Of Losses
finance.yahoo.com - September 25 at 12:26 PM
finance.yahoo.com logoDaiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer Drug
finance.yahoo.com - September 25 at 7:22 AM
finance.yahoo.com logoStock Market Today: Bond Yields Climb Toward 4.5%
finance.yahoo.com - September 25 at 7:22 AM
finance.yahoo.com logoNikkei Flat, Supported by Electronics, Pharma Stocks
finance.yahoo.com - September 24 at 8:45 PM
finance.yahoo.com logoDatopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial
finance.yahoo.com - September 22 at 10:17 AM
finance.yahoo.com logoAstraZeneca Surges To 50-Day Line After Breast Cancer Drug Tops Chemo
finance.yahoo.com - September 22 at 10:17 AM
lse.co.uk logoAstraZeneca and Daiichi Sankyo's Enhertu recommended for approval
lse.co.uk - September 15 at 2:21 PM
finance.yahoo.com logoUPDATE 1-EU regulator backs AstraZeneca and Daiichi's lung cancer drug
finance.yahoo.com - September 15 at 2:21 PM
bloomberg.com logoDaiichi to File for US Approval of New Lung Cancer Drug by March
bloomberg.com - September 12 at 2:07 AM
finance.yahoo.com logoPatritumab Deruxtecan Demonstrated Clinically Meaningful and Durable Responses in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer in HERTHENA-Lung01 Phase 2 Trial
finance.yahoo.com - September 10 at 5:33 AM
finance.yahoo.com logoIfinatamab Deruxtecan Continues to Demonstrate Durable Responses in Patients with Advanced Small Cell Lung Cancer in Early Trial
finance.yahoo.com - September 10 at 5:33 AM
finance.yahoo.com logoDS-3939 Enters Clinical Development in Patients Across Several Types of Advanced Solid Cancers
finance.yahoo.com - September 7 at 7:09 PM
abcnews.go.com logoThe Fukushima Daiichi nuclear power plant has begun releasing its first batch of treated radioactive water into the sea
abcnews.go.com - August 24 at 5:51 PM
lse.co.uk logoDaiichi Sankyo and AstraZeneca's Enhertu wins new approval in Japan
lse.co.uk - August 23 at 3:48 AM
finance.yahoo.com logoDaiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients with Lung Cancer with Data Across DXd ADC Portfolio at WCLC
finance.yahoo.com - August 16 at 3:50 PM
finance.yahoo.com logoVANFLYTA® Now Available in U.S. for Patients with Newly Diagnosed FLT3-ITD Positive AML
finance.yahoo.com - August 9 at 8:08 AM
finance.yahoo.com logoENHERTU® Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial
finance.yahoo.com - July 27 at 2:28 AM
benzinga.com logoFDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt
benzinga.com - July 21 at 1:12 PM
news.yahoo.com logoJapan's Daiichi Sankyo gets US FDA nod for blood cancer therapy
news.yahoo.com - July 20 at 7:52 PM
Get Daiichi Sankyo News Delivered to You Automatically

Sign up to receive the latest news and ratings for DSNKY and its competitors with MarketBeat's FREE daily newsletter.



DSNKY Media Mentions By Week

DSNKY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DSNKY
News Sentiment

-0.50

0.63

Average
Medical
News Sentiment

DSNKY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DSNKY Articles
This Week

2

1

DSNKY Articles
Average Week

Get Daiichi Sankyo News Delivered to You Automatically

Sign up to receive the latest news and ratings for DSNKY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:DSNKY) was last updated on 3/2/2024 by MarketBeat.com Staff